Skip to content

Efficacy and safety of low intensity pulsed ultrasound for knee osteoarthritis: a prospective, randomized controlled trial protocol

Efficacy and safety of low intensity pulsed ultrasound for knee osteoarthritis: a prospective, randomized controlled trial protocol

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-14005748
Enrollment
Unknown
Registered
2014-12-26
Start date
2015-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

treatment group:LIPUS+diclofenac
control group :sham LIPUS+diclofenac

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to American College of Rheumatology (ACR) criteria for symptomatic knee OA assessed by a rheumatologist; 2. Men and women aged between 40 and 80; 3. KelIgren-Lawrence grade rating of I, II and III; 4. Not receiving corticosteroids for more than six months; 5. Not receiving NSAIDs, intraarticular hyaluronan, SYSADOA and other treatment for more than two weeks; 6. Signed informed consent; 7. Able to attend 1 intervention sessions(10 days).

Exclusion criteria

Exclusion criteria: 1. Rheumatoid and rheumatic arthritis, infectional arthritis, gouty arthritis diseases; 2. Patients with severe mental and neurologic diseases; 3. Patients with knee skin ulceration and infections, serious operation or traumatic scar, joint local malignant tumor and joint replacement; 4. Patients with gastrointestinal ulcer and bleeding, severe liver and kidney dysfunction, cardiovascular disease, artificial heart pacemaker and uncontrolled hypertension; 5. Knee pain and disfunction caused by other diseases; 6. Patients with connective tissue disease (e.g.SLE); 7. unable to fulfil the forms.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;WOMAC-VA3.1;

Secondary

MeasureTime frame
Lequesne index;SF-36;

Countries

China

Contacts

Public ContactChen Wen-zhi
chenwz@cqmu.edu.cn+86 13608335926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026